DU.S. Drug Administration Food and Drug Administration The warning states that after being vaccinated with Johnson & Johnson’s coronavirus vaccine, there will be an “increased risk” of developing rare neurological diseases. After reporting dozens of cases of the so-called Guillain-Barré syndrome, the FDA updated its warning on Monday.
According to information provided by people familiar with the matter, there are 100 initial reports of neurological diseases with paralytic symptoms-about 12.5 million doses of Johnson & Johnson vaccine have been injected. In 95 cases, the patient had to be hospitalized. One person died.
Influenza vaccination can also cause the syndrome
In the United States, there are between 3,000 and 6,000 Guillain-Barré syndromes every year. Inflammatory neurological diseases cause muscle weakness and paralysis. Most patients recover. This syndrome has also been observed in some influenza vaccination.
The FDA’s new warning is another setback for Johnson & Johnson. In April, the American pharmaceutical company temporarily stopped using the coronavirus vaccine after a rare case of blood clots, especially among young women. However, the authorities concluded that the benefits of vaccination clearly outweigh the risks. A major production failure at a factory in Baltimore, USA also made headlines.
Johnson & Johnson’s vaccine requires only one dose and plays a secondary role in the US vaccination campaign. So far, less than 13 million doses of vaccine have been vaccinated.There are already more than 185 million Biontech-Pfizer corona vaccines vaccine Biotechnology company Moderna has more than $135 million.
